Proteus Biomedical - Dallas, Texas 75287

Proteus Biomedical is categorized under Doctors in Dallas, TX .

Business Name: Proteus Biomedical
Contact Person: Michael Cichy
Address: 4304 Firebrick Lane, Dallas, Texas 75287
Phone Number: (214) 497-0189
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Jackson-Merica & Associates Inc - Dallas, TX 75287
Frisco Hand Extremity Specialist - Dallas, TX 75287
Law-Yone Byron MD - Dallas, TX 75287
Schoen Matthew S MD - Dallas, TX 75287
Stephen A Redfern Md - Dallas, TX 75287
Scott Meril M D P A - Dallas, TX 75287
Elite Foot-Ankle - Dallas, TX 75287
Christopher A Clarke M D P A - Dallas, TX 75287
Burns Carol MD - Dallas, TX 75287
Trinity Marsh Medical Clinic - Dallas, TX 75287
Wills John S MD - Dallas, TX 75287
North Ga Physician Service - Dallas, TX 75287
Reihsen Julie L MD - Dallas, TX 75287
Steven Davidoff Md Pa - Dallas, TX 75287
Donna K Haas O D P C - Dallas, TX 75287
Mizzou Rah Investments LLC - Dallas, TX 75287
Derryberry Dr - Dallas, TX 75287
Olvera David A MD - Dallas, TX 75287
Bergman Karin K MD - Dallas, TX 75287
Patil Rajashri MD - Dallas, TX 75287

The company Proteus Biomedical provides B2C services in the form of Doctors from its single location in Texas. 1 to 4 employees work for Proteus Biomedical, and the business now earns $100.000 to $499.999 per annum.

Proteus Biomedical was launched in 2011 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact Proteus Biomedical, please call Michael Cichy with the phone number (214) 497-0189 or visit its single location at 4304 Firebrick Lane in Dallas, Texas 75287.

The location of the single location can also be found using the coordinates 32.998771,-96.835762. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.